SightGlass Vision
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, SightGlass Vision sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
SightGlass Vision: 8 sponsored US clinical trials, 3 recruiting.
SightGlass Vision sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Juvenile Myopia, with 7 trials.
Upper-quartile sponsor footprint
SightGlass Vision sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
NCT07229352
Children's Viewing Behavior
NCT07229365
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NCT06034327
Myopia Control Spectacle Lens Cessation Study
NCT05893979
Spectacle Lens Visual Acuity Assessments Study
NCT05650190
CYPRESS Efficacy and Safety Study Extension
NCT04947735
Control of Myopia Using Novel Spectacle Lens Designs
NCT03623074
Myopia Assessment of Two Manufacturing Processes
NCT04126057
Therapeutic Areas
What is open in the SightGlass Vision pipeline
3 recruiting of 8 indexed (38% open); 1 completed (13%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Juvenile Myopia (7 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
SightGlass Vision: open-pipeline peers nationwide
Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
SightGlass Vision sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 38% open enrollment (± trial volume)
- American Thrombosis and Hemostasis Network · 38% recruiting · 8 trials
- AskBio · 38% recruiting · 8 trials
- Athletic Greens International · 38% recruiting · 8 trials
- Banner Health · 38% recruiting · 8 trials
Related
What to do with this SightGlass Vision page
8 registered trials is a research-attention snapshot, not an endorsement of SightGlass Vision or any single study.
- 3 of SightGlass Vision's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Juvenile Myopia is the condition SightGlass Vision studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Juvenile Myopia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
SightGlass Vision pipeline card: 8 registered trials from official public datasets.Report a data error.